Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neuflo Water Electrolysis System for the Treatment of Benign Prostatic Hyperplasia

NCT05884580 is registered in ClinicalTrials.gov with ProstaCare Pty Ltd as lead sponsor.

NCT NCT05884580
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05884580 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neuflo Water Electrolysis System for the Treatment of Benign Prostatic Hyperplasia
Lead sponsor
ProstaCare Pty Ltd
Phase
Not applicable
Overall status
Terminated
Start date
November 10, 2023
Completion date
January 10, 2026
Enrollment
1 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

benign prostatic hyperplasia, lower urinary tract symptoms